![Clay Thorp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clay Thorp
Fondatore presso
PHASEBIO PHARMACEUTICALS, INC.
Profilo
Clay Bernardin Thorp is the founder of PhaseBio Pharmaceuticals, Inc., founded in 2002, serving as Chairman since 2014.
Mr. Thorp is the founder of Hatteras Venture Partners, founded in 2000, serving as General Partner since 2000.
Mr. Thorp is also the founder of Synthematix, Inc.,Karo Bio USA, Inc.,Xanthon, Inc...
Mr. Thorp is Chairman at Clearside Biomedical, Inc. since 2012.
Mr. Thorp is Director at GeneCentric Therapeutics, Inc., Rodin Therapeutics, Inc., Curoverse, Inc., Seaport Diagnostics, Inc., StrideBio, Inc., and North Carolina School of Science & Mathematics Foundation.
Mr. Thorp is Member-Visitors Board at Lineberger Comprehensive Cancer Center.
Mr. Thorp was Director at CancerGuide Diagnostics, Inc., Device Innovation Group LLC, Pathfinder Therapeutics, Inc., G1 Therapeutics, Inc., Lysosomal Therapeutics, Inc., and Vigil Neuroscience, Inc. from 2020 to 2022.
Mr. Thorp was Advisor at Research Triangle Ventures LLC.
Mr. Thorp completed graduate studies at Harvard University in 1994.
Mr. Thorp completed undergraduate studies at The University of North Carolina at Chapel Hill in 1990.
Posizioni attive di Clay Thorp
| Società | Posizione | Inizio |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Fondatore | 10/01/2002 |
| CLEARSIDE BIOMEDICAL, INC. | Presidente | 13/08/2025 |
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Presidente | - |
Lineberger Comprehensive Cancer Center
 Lineberger Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer research and treatment center | Corporate Officer/Principal | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Direttore/Membro del Consiglio | - |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Direttore/Membro del Consiglio | - |
Curoverse, Inc.
 Curoverse, Inc. Packaged SoftwareTechnology Services Develops an open-source software to manage, computation and sharing for big genomic data | Direttore/Membro del Consiglio | - |
Seaport Diagnostics, Inc.
 Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Direttore/Membro del Consiglio | - |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Fondatore | 01/05/2000 |
| ░░░░░ ░░░░░░░░ ░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Clay Thorp
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formazione di Clay Thorp
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
22
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 22 |
|---|---|
Synthematix, Inc.
 Synthematix, Inc. Packaged SoftwareTechnology Services Develops software to assist in chemistry research | Technology Services |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
CancerGuide Diagnostics, Inc.
 CancerGuide Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops and markets tests to support individualized cancer therapy decisions | Health Services |
Device Innovation Group LLC
 Device Innovation Group LLC Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karo Bio USA, Inc.
 Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug discovery technologies | Commercial Services |
Xanthon, Inc.
 Xanthon, Inc. Packaged SoftwareTechnology Services Develops enterprise software solutions | Technology Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Triangle Ventures LLC
 Research Triangle Ventures LLC Investment ManagersFinance Research Triangle Ventures invests in emerging, high growth companies located in the Southeastern US with an emphasis on the Research Triangle area of North Carolina | Finance |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Pathfinder Therapeutics, Inc.
 Pathfinder Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops computer-assisted surgical navigation products for soft tissue organ surgeries | Health Technology |
Lineberger Comprehensive Cancer Center
Lineberger Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer research and treatment center | Health Services |
North Carolina School of Science & Mathematics Foundation | Consumer Services |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Curoverse, Inc.
Curoverse, Inc. Packaged SoftwareTechnology Services Develops an open-source software to manage, computation and sharing for big genomic data | Technology Services |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Health Services |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
